Trial intelligence / Profile preview

Adenosine’s Effect on Stunning Resolution in Acute Myocardial Infarction

2021-001466-37Phase 2Terminated

Sponsor: Region Västra Götaland
Start: Apr 2021
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Phase 2 trial of adenosine in myocardial infarction (MI), sponsored by Region Västra Götaland. Primary endpoint: StunningRes48h. Started Apr 2021; status: terminated.

Drugs

adenosine

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2021-001466-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-001466-37.